Former Philippines president to attend senate probe on Sanofi's Dengvaxia vaccine
26 February 2018
Sanofi to buy Belgian biotech company Ablynx for $4.8 bn
29 January 2018
Sanofi in pact to acquire US biotech haemophila drugs maker Bioverativ for 11.6 bn
22 January 2018
Drugmaker Sanofi under fire over Dengvaxia reverse
18 December 2017
WHO to review Sanofiís dengue vaccine Dengvaxia over safety concerns
05 December 2017
French drug giant Sanofi not to sell chemical division Cepia
06 May 2017
FDA approves Dupixent to treat severe eczema
29 March 2017
Sanofi nears deal to sell some OTC products to Ipsen SA
13 February 2017
Regeneron and Sanofi need not pull Praluent off market
09 February 2017
US regulator orders divestitures in Boehringer-Sanofi asset swap deal
29 December 2016
Sanofi mulls counter bid for Swiss biotech company Actelion
06 December 2016
New cholesterol drug not worth the high price, finds study
19 August 2016
Boehringer Ingelheim offers concession to EU for its $25-bn asset swap with Sanofi
09 July 2016
US cancer drug company Medivation finally allows Sanofi to conduct due diligence
07 July 2016
Sanofi Pasteur signs research agreement with US Army on Zika vaccine
06 July 2016
Sanofi prepares to replace Medivation's board
14 May 2016
Sanofi threatens to oust Medivation board if it does not engage in takeover talks
06 May 2016
Sanofi tables $9.3-bn bid for US biotech firm Medivation
28 April 2016
Sanofi mulls selling animal health unit and European generics business worth over $13 bn
07 November 2015
Sanofi strikes Ä3.5 bn diabetes treatment development deal with Hanmi Pharmaceutical
05 November 2015
French drug maker Sanofi recalls epinephrine injectors
02 November 2015
Sanofi, Pfizer, Abbott eye Mexican generic drug maker Rimsa
21 September 2015
Sanofi to buy AstraZeneca's cancer drug for upto $300 mn
27 July 2015
CCI Imposes Rs64 crore fine on GlaxoSmithKline, Sanofi
06 June 2015
Sanofi Emcure in pact to market oncology drugs
06 August 2014
Sanofi announces results of first Phase III dengue vaccine in The Lancet
14 July 2014
Sanofi unit Genzyme in alliance with Alnylam Pharmaceuticals to develop RNAi therapeutics
13 January 2014
Sanofi fails to win US FDA approval for Genzyme's MS drug Lemtrada
30 December 2013
Sanofi, Shire eye US rare diseases drug maker ViroPharma
14 September 2013
Sanofi becomes latest drug firm under Chinese probe for bribery
12 August 2013
Andhra HC quashes tax demand on Sanofi over Shantha Biotech buyout
15 February 2013
INDOX expansion boosts cancer research across India
04 February 2013
Sanofi still in the race for Bayerí blood glusose testing business: report
08 December 2012
Sanofi to acquire Colombian affordable drugmaker Genfar
03 October 2012
Sanofi to eliminate 900 R&D jobs in France
26 September 2012
Sanofi to acquire US medical device company Pluromed to expand in biosurgery
16 March 2012
Lupin, Sanofi-Aventis Philippines in strategic agreement
05 September 2011
Sanofi plans Rs450-cr OTC deal with Universal Medicare
23 August 2011
Sanofi to sell skincare business to Canada's Valeant Pharmaceuticals for $425 mn
11 July 2011
Sanofi-Aventis shortens name to Sanofi
07 May 2011
Merck, Sanofi Pasteur start Phase-3 trials of paediatric combination vaccine in US
23 April 2011
Sanofi-Aventis, Genzyme in talks to structure $80 per share deal
08 January 2011
Sanofi-Aventis extends Genzyme offer, terms unchanged
13 December 2010
Aventis to exit Chiron JV with Novartis, with Rs105-crore stake sale
13 December 2010
Sanofi-Aventis goes hostile with $18.5-bn Genzyme bid
04 October 2010
Sanofi Aventis reportedly raises offer to $71 per share
09 September 2010
Genzyme board rejects Sanofi-Aventis $18.5-billion takeover offer
31 August 2010
Sanofi-Aventis reveals $18.5-billion offer for Genzyme
30 August 2010
Genzyme begins takeover talks with Sanofi-Aventis
03 August 2010
Glaxo follows Sanofi-Aventis to biotech major Genzyme
26 July 2010
Sanofi-Aventis targets troubled Genzyme Corp for takeover
24 July 2010
Sanofi-Aventis gearing to make US acquisition worth $20 billion: report
03 July 2010
Sanofi-Aventis to buy US oncology products firm TargeGen for $560 million
30 June 2010
Sanofi-Aventis signs global licensing pact with Metabolex for Type II diabetes drug
25 June 2010
Sanofi-Aventis signs $750-million microRNA therapeutics deal with Regulus
22 June 2010
Sanofi Aventis signs antibody research deal with Vivalis SA
09 June 2010
Sanofi-Aventis signs $398-million cancer drug license deal with Ascenta Therapeutics
04 June 2010
Sanofi-Aventis and Nichi-Iko Pharmaceutical to form generic drug JV
29 May 2010
Glenmark in $325-million drug deal with Sanofi-Aventis
03 May 2010
US court bans Sun Pharma's generic equivalent of Sanofi's eloxatin
24 April 2010
Sanofi-Aventis in $335-million diabetes drug deal with CureDM
08 April 2010
Sanofi-Aventis settles patent infringement suit with generic drug manufacturers
03 April 2010
Sanofi-Aventis concludes Chattem acquisition
13 March 2010
Sanofi-Aventis commences tender offer for Chattem
11 January 2010
Sanofi-aventis to acquire Chattem for $1.9 billion
21 December 2009
Sanofi-Aventis signs drug localisation pact with Russia
28 November 2009
Sanofi-Aventis expands Regeneron research deal to $1 billion
11 November 2009
AstraZeneca says its new anti-clotting drug better than Plavix
31 August 2009
Sanofi-Aventis to acquire Merck's Merial stake for $4 billion
30 July 2009
Sanofi-Aventis to acquire Shantha Biotech for Rs3,757 crore
27 July 2009
Sanofiís diabetes drug may increase cancer risk: European study
27 June 2009
Sanofi-Aventis inks cancer drug research deal with Exelixis
29 May 2009
Sanofi to buy US cancer drug firm for about $500 million
15 April 2009
Glaxo, Sanofi in talks for Shanta Biotch takeover
30 March 2009
PPF ends opposition to Zentiva sale; Sanofi takeover likely
11 February 2009
Sanofi settles Allegra, Nasacort patent suits with Teva, Barr
20 November 2008
French pharma Sanofi-Aventis acquires Zentiva for $2.6 billion
23 September 2008
Sanofi-aventis to acquire Symbion Holdings for $544 million
21 July 2008
Zentiva turns down PPF subsidiary Anthiarose as Sanofi makes rival bid
23 June 2008
Top two shareholders, including Sanofi-Aventis, launch competing bids for Czech drugmaker Zentiva
19 June 2008
Sanofi commits 60 million doses of H5N1 vaccine for WHO global H5N1 vaccine stockpile
16 June 2008
French drug giant Sanofi-Aventis opens R&D centre in Goa
05 December 2007
Dr Reddy's in discussions with Sanofi-Aventis to settle Plavix litigation
22 March 2006
 search domain-b